The overall market was estimated to be $471.7 million in FY2019, and it is expected to grow at a CAGR of 44.03% during the forecast period, 2021-2030

    NEXT STORY
    Published Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift® System Compared to Medications Prescribed for Benign Prostatic Hyperplasia
    PREV STORY
    Orion publishes Financial Statement Release for 2020 on Tuesday 9 February 2021
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2020-30: COVID-19 Growth and Change

    author_avatar
    NASDAQ Market News

    Asterias Biotherapeutics Announces Positive Outcome from Second Safety Review Committee Meeting and Open Enrollment for VAC2 Clinical Trial in Non-Small Cell Lung Cancer (NSCLC)

    Two Sites in the UK Currently Enrolling PatientsFREMONT, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) ...

    author_avatar
    NASDAQ Market News

    XBiotech berichtet über Entwicklungen im dritten Quartal 2018

    Unternehmen stellt aktualisierte Übersicht zur klinischen und Entdeckungs-Pipeline sowie anderen Unternehmensinitiativen vor AUSTIN, Texas, ...

    author_avatar
    NASDAQ Market News